A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Fibrocystic Breast Condition (FBC)

Interventions

DIETARY_SUPPLEMENT

Violet™ Molecular Iodine (I2)

OTHER

Placebo

Trial Locations (2)

KGK Synergize, Orlando

KGK Synergize, London